Rationale and design of the randomised controlled trial to assess the impact of liraglutide on cardiac function and structure in young adults with type 2 diabetes (the LYDIA study).

Cardiovasc Diabetol · 2016 · PMC4955217 · PMID 27440110

Europe PMC DOI

hedged sentence

0.0800

closest p · 1.6× alpha

0.0800

boldest claim

The sentences

a strong trendp = 0.08so close (0.05 < p ≤ 0.1)

There was also a strong trend towards reduced systolic strain in T2DM (21 %) compared to both control groups (23 % p = 0.08), suggesting these patients may be on the verge of developing systolic as well as diastolic impairment.

also in 5,725 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.